stockrowKiniksa Pharmaceuticals International, plc
KNSA Healthcare Drug Manufacturers Specialty & Generic
Kiniksa Pharmaceuticals International, plc’s revenue for fiscal 2025 (year ended December 2025) was $677.6 million, up 60.1% from fiscal 2024.
- Revenue
- +58.1%
- EPS
- +142.2%
- Free cash flow
- +43.5%
Quarter to September 2026, against a year earlier
Follow KNSA
Alert me
Kiniksa Pharmaceuticals International, plc (KNSA) Operating margin
Kiniksa Pharmaceuticals International, plc's operating margin over the twelve months to 30 September 2026 was 13.8%, up 2.4 percentage points from fiscal 2025 (11.4%). Over the past ten years it has ranged from −406.4% (fiscal 2021) to 11.4% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers Specialty & Generic industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 11.4% | 22.18 |
| FY2024 | −10.8% | (1.46) |
| FY2023 | −9.32% | (13.76) |
| FY2022 | 4.44% | 410.82 |
| FY2021 | −406.4% | (406.38) |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | 0.00 |
| FY2016 | 0.00% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 19.0% | 7.81 |
| Jun 2026 | 11.2% | (2.50) |
| Mar 2026 | 13.7% | 3.88 |
| Dec 2025 | 9.78% | (3.50) |
| 33 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| SUPN Indivior Pharmaceuticals Inc. compare | 40.6% |
| LQDA Liquidia Corporation compare | 37.4% |
| LNTH Lantheus Holdings, Inc. compare | 18.6% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 15.0% |
| KNSA Kiniksa Pharmaceuticals International, plc | 13.8% |
| RDY Dr. Reddy's Laboratories Ltd compare | 9.20% |
| ALKS Alkermes plc compare | 3.66% |
| ELAN Elanco Animal Health Incorporated compare | 1.61% |
| HIMS Hims & Hers Health, Inc. compare | −5.99% |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on KNSA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement